Hims & Hers Health Sees Q2 Sales $680.000M-$700.000M vs $642.946M Est

Benzinga Newsdesk www.benzinga.com Positive 84.7%

Neg 0% Neu 0% Pos 84.7%

Hims & Hers Health (NYSE:HIMS) sees Q2 sales of $680.000 million-$700.000 million vs $642.946 million analyst estimate.

Comments

No comments yet. Be the first!

Hims &amp; Hers Health Sees Q2 Sales $680.000M-$700.000M vs $642.946M Est